Comparing insulins detemir and glargine in type 2 diabetes: more similarities than differences. Commentary.

The efficacy of either detemir or glargine is comparable in subjects with type 2 diabetes when combined with insulin aspart in a basal-bolus regimen. Subjects randomized to detemir used slightly higher daily insulin doses, but gained less weight on average than glargine-treated subjects.

RCT Entities:   Population Interventions Outcomes